Intravitreal Injection of Triamcinolone Acetonide in Retinitis
Not Applicable
- Conditions
- cystoids macular edema (CME) secondary to retinitis pigmentosa (RP).
- Registration Number
- IRCT201104266293N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 161
Inclusion Criteria
diagnosis of RP based on paraclinic tests
Exclusion criteria: one-eyed patients, history of glaucoma, any opacity in media and history of intraocular surgery
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity. Timepoint: 3 weeks, 3 months and 6 months after the injection. Method of measurement: snellen chart.
- Secondary Outcome Measures
Name Time Method Macular thickness and angiographic changes. Timepoint: 3 weeks, 3 and 6 months after the injection. Method of measurement: Slit lamp examination, fundoscopy and OCT.